Postconditioning Rotterdam Trial
Recruiting
- Conditions
- myocardial infarction, primairy PCI, STEMI, thrombectmy, postconditioning, MRI
- Registration Number
- NL-OMON26072
- Lead Sponsor
- Felix Zijlstra, MD, PhD and Olivier Manintveld, MD, PhD (Thoraxcenter, Erasmus MC, Rotterdam, the Netherlands)
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 72
Inclusion Criteria
Patients are included in the study when written informed consent is given. Consecutive patients as defined above are screened for inclusion in the trial. The eligibility criteria consist of the following:
1. Delay between onset of chest pain and PCI ≤ 6 hours in case of inferiolateral wall infarction and ≤ 12 hours in case of anterior wall infarction;
Exclusion Criteria
1. Younger than 18 or older than 75 years of age;
2. Cardiogenic shock defined as sustained systolic blood pressure ≤ 80 mmHg despite fluid hydration and/or the inability to discontinue vasopressors in less than 1 hour before;
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Difference of myocardial infarct size between treatment groups measured on delayed enhance (DE) MRI at 3 months.
- Secondary Outcome Measures
Name Time Method